ATP5F1A and in situ carcinoma: Atp5a1, a protein of the ATP synthase complex that in soluble form may play a role in regulating gene expression and alternative splicing [24], subsequentially appeared at 24 h in LH and CIS + LH but not in CIS, implying an inhibitory action by the drug removed by LH.